Arginine reprograms metabolism in liver cancer via RBM39

精氨酸通过RBM39重编程肝癌细胞的代谢

阅读:3
作者:Dirk Mossmann ,Christoph Müller ,Sujin Park ,Brendan Ryback ,Marco Colombi ,Nathalie Ritter ,Diana Weißenberger ,Eva Dazert ,Mairene Coto-Llerena ,Sandro Nuciforo ,Lauriane Blukacz ,Caner Ercan ,Veronica Jimenez ,Salvatore Piscuoglio ,Fatima Bosch ,Luigi M Terracciano ,Uwe Sauer ,Markus H Heim ,Michael N Hall

Abstract

Metabolic reprogramming is a hallmark of cancer. However, mechanisms underlying metabolic reprogramming and how altered metabolism in turn enhances tumorigenicity are poorly understood. Here, we report that arginine levels are elevated in murine and patient hepatocellular carcinoma (HCC), despite reduced expression of arginine synthesis genes. Tumor cells accumulate high levels of arginine due to increased uptake and reduced arginine-to-polyamine conversion. Importantly, the high levels of arginine promote tumor formation via further metabolic reprogramming, including changes in glucose, amino acid, nucleotide, and fatty acid metabolism. Mechanistically, arginine binds RNA-binding motif protein 39 (RBM39) to control expression of metabolic genes. RBM39-mediated upregulation of asparagine synthesis leads to enhanced arginine uptake, creating a positive feedback loop to sustain high arginine levels and oncogenic metabolism. Thus, arginine is a second messenger-like molecule that reprograms metabolism to promote tumor growth. Keywords: AGMAT; ARG1; ASNS; RBM39; arginine; hepatocellular carcinoma; indisulam; metabolism.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。